Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools
Log in
Sections
You are here: Home Biostatistics and Clinical Data Management Allison M. Deal, M.S.

Allison M. Deal, M.S.

Allison Deal

Biostatistician

Biostatistics and Clinical Data Management Core Facility

919-966-1387

Allison_Deal@med.unc.edu

 

Education

M.S. Biostatistics, University of North Carolina, 2007
B.S. Statistics, Pennsylvania State University, 2005
B.S. Mathematics, Pennsylvania State University, 2005

Publications

Ollila DW, J Ashburn, KD Amos, JJ Yeh, JS Frank, AM Deal, P Long, ND Thomas, MO Meyers. “Metastatic Melanoma Cells in the Sentinel Node Cannot be Ignored.” Journal of American College of Surgeons. (2009)Volume 208 (5).

Patel MR, PC Bryson, CG Shores, CF Hart LB Thorne, AM Deal, AM Zanation.  “Trefoil Factor 3 (TFF-3) Immunohistochemistry Characterization of Follicular Thyroid Lesions from Tissue Microarray.” Archives of Otolaryngology Head & Neck Surgery. (2009) 135(6):590-596.

Meyers MO, JJ Yeh, J Frank, P Long, AM Deal, KD Amos, DW Ollila. “Method of Detection of Initial Recurrence of Stage II/III Cutaneous Melanoma: Analysis of the Utility of Follow-Up Staging.” Annals of Surgical Oncology. (2009) 16:941–947.

Patel M, Deal AM, Shockley WW. “Oral and Plunging Ranulas: What is the most effective treatment?” The Laryngoscope. (2009) 119:1501-1509.

Blatt J, AM Deal, G Mesibov. “Autism in Children and Adolescents with Cancer: A Pilot Study.” Pediatric Blood & Cancer, (2010) 54:144-147.

Puvvada, SD, WK Funkhouser, K Greene, AM Deal, H Chu, AS Baldwin, JE Tepper, BH O'Neil. “Prognostic implication of NF-κB and BCL3 activation in metastatic colorectal cancer.” Oncology, (2010) 78(3-4): 181-188.

O’Neil, BH, WK Funkhouser, BF Calvo, MO Meyers, HJ Kim, RM Goldberg, SA Bernard, L Caskey, AM Deal, F Wright, AS Baldwin, JE Tepper. “NF-κB is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiation.” International Journal of Radiation Oncology- Biology-Physics, (2010) In Press.

Seaman WT, E Andrews, M Couch, EM Kojic, S Cu-Uvin, J Palefsky, AM Deal, J Webster-Cyriaque. “Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.” Virology Journal, (2010) 7:194.

Watson RG, F Muhale, LB Thorne, J Yu, BH O’Neil, JM Hoskins, MO Meyers, AM Deal, JG Ibrahim, ML Hudson, CM Walko, HL McLeod, JT Auman, “Amplification of Thymidylate Synthetase in Metastatic Colorectal Cancer Patients Pretreated with 5-Fluorouracil-based Chemotherapy.” European Journal of Cancer, (2010)46(18): 3358-3364.

Meyers, MO, JJ Yeh, AM Deal, FL Byerly, JT Woosley, J Frank, PK Long, KD Amos, DW Ollila, “Age and Breslow Depth Are Associated With a Positive Sentinel Lymph Node in Patients with Cutaneous Melanocytic Tumors of Uncertain Malignant Potential.” Journal of the American College of Surgeons, (2010)211(6): 744-748.

Anders, CK, AM Deal, C Khorram, H Meng, E Burrows, C Livasy, K Fritchie, MG Ewend, CM Perou, LA Carey. “The Prognostic Contribution of Clinical Breast Cancer Subtype, Age and Race among Patients with Breast Cancer Brain Metastases.” Cancer, (2010)In Press.

Cates, JR, A Shafer, SJ Diehl, AM Deal. “Evaluating a County-Sponsored Social Marketing Campaign to Increase Mothers’ Initiation of HPV Vaccine for their Pre-teen Daughters in a Primarily Rural Area.” Social Marketing Quarterly, (2010) In Press.

Getting Started

For new requests, a good first step may be to meet with one of us at our Walk-In Clinic.

Otherwise, please feel free to contact us by e-mailing Michael ChiuAllison M. Deal, Dominic T. Moore, or .

For ongoing work, please use e-mail to contact the individual who is your main contact person for your Cancer Center Biostatistics and/or Clinical Data Management activity.

For urgent matters, please call Dominic at 919-966-8647.

Software

For access to free software for the design and analysis of clinical trials, click on the software links next to faculty and staff names.

Walk-In Clinic Hours

Now available on Tuesdays and Thursdays

12 noon to 1 p.m.

in the atrium on the first floor of the Lineberger building

What is a walk-in clinic? Learn more!

Welcome Dr. Anna Snavely

Born in Greensboro, Anna earned her undergraduate degree in mathematics with a concentration in statistics from Wake Forest University.  She completed her PhD in Biostatistics at Harvard University in 2012. Her dissertation work was motivated by cancer clinical trials and involved methods for analyzing clustered survival and multiple outcomes data.

While at Harvard, Anna was involved in many collaborative projects at Dana-Farber Cancer Institute. In particular, she worked with investigators at the Center for Community-Based Research, the Head and Neck Cancer Program, and the Lance Armstrong Foundation Adult Survivorship Program.

We are very pleased to have Anna with us! Please join us in welcoming her to our Cancer Center.